DBV Technologies announced that new clinical study results on the use of Viaskin? Peanut (DBV712) 250 ?g in children will be presented at the American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting, Nov. 4-8, 2021. Two abstracts have been accepted, including one oral presentation and one poster presentation. These presentations will be available on DBV?s website, www.dbv-technologies.com, following the conclusion of the meeting for those who are unable to attend. DBV will also host a booth in the ACAAI exhibit hall. The data to be presented include new long-term results of the Phase 3 REALISE (REAL Life Use and Safety of EPIT?) study in children 4-11 years of age, including the safety of Viaskin Peanut over three years and potential impact on health-related quality of life (HRQL). DBV is also sponsoring the 30th Annual FIT Bowl, a game show-type competition that tests the knowledge of participating teams from training programs around the country. Viaskin Peanut is the Company?s lead product candidate designed to reduce the risk of allergic reactions due to accidental exposure to peanuts. An investigational non-invasive, once daily, epicutaneous patch, Viaskin Peanut seeks to deliver microgram quantities of peanut antigen to re-educate the immune system. Viaskin Peanut is DBV?s proprietary approach to epicutaneous immunotherapy (EPIT), a method of delivering biologically active compounds to the immune system through the skin. REALISE (Real-life Use and Safety of EPIT) Study: 3 Year Results in Peanut-Allergic Children? will be presented by Terri Brown-Whitehorn, MD, Children?s Hospital of Philadelphia, Philadelphia, PA. Session Code: D030. Session Title: Distinguished Industry Oral Abstracts ? Session B. Presentation Date: Saturday, November 6, 2021. Presentation Time: 4:33-4:43 pm CT. Poster Presentation ?REALISE (Real-life Use and Safety of EPIT) Study: Health-related Quality of Life Changes During Treatment?will be presented by Dareen Siri, MD, Midwest Allergy Sinus Asthma SC, Normal, IL. Abstract Number: P116. Presentation Date: Saturday, November 6, 2021. Presentation Time: 12:35 pm CT. Presentation Location: Monitor 11 in the ePoster Area of the Exhibit Hall.